Immunoglobulins Shigellosis To Sonne Antigens

Shigella immunoglobulins to Sonne antigens: description and application

Shigella immunoglobulins to Sonne antigens are a medical product that is used to diagnose and treat infections caused by the Shigella bacterium. The drug is produced in Russia by the Scientific Research Institute of EM, an enterprise for the production of bacterial preparations named after. N.F. Gamaleya.

Shigella immunoglobulins to Sonne antigens belong to a group of immunoglobulins, which are antibodies produced by the body in response to infection. They bind to Shigella antigens and help the body fight infection.

This drug is used to diagnose infections caused by Shigella. For this purpose, the immunofluorescence method is used, in which Shigella immunoglobulins to Sonne antigens bind to Shigella antigens on a sample of the patient’s biomaterial. If there are infectious agents in the sample, they will be associated with immunoglobulins, which can be detected using a fluorescence microscope.

Shigella immunoglobulins to Sonne antigens can also be used to treat infections caused by Shigella. They are introduced into the patient's body as anti-infective therapy.

The dosage form of shigella immunoglobulins to Sonne antigens is a diagnostic fluorescent dry ampoule preparation with a volume of 0.5 ml.

Despite the fact that Shigella immunoglobulins to Sonne antigens are produced only in Russia, they can be used for the diagnosis and treatment of infections caused by Shigella in any country in the world.

Despite the high efficiency and safety, the use of immunoglobulins